Clinical trial
A Phase 1b Extension Trial To Allow Repeat Intracerebroventricular Injections of Ex Vivo Expanded, Autologous Adipose-Derived Stem Cells (RB-ADSCs) in Subjects Previously Treated in RBI Protocol RB-ADSC-02
NCT07373067 is registered in ClinicalTrials.gov with Regeneration Biomedical, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1b Extension Trial To Allow Repeat Intracerebroventricular Injections of Ex Vivo Expanded, Autologous Adipose-Derived Stem Cells (RB-ADSCs) in Subjects Previously Treated in RBI Protocol RB-ADSC-02
- Lead sponsor
- Regeneration Biomedical, Inc.
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- September 30, 2026
- Completion date
- September 30, 2028
- Enrollment
- 9 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.